Article Text

PDF
Cost-effectiveness study
Colorectal cancer screening is cost-effective in the elderly who have had less intense prior screening, high baseline risk of colorectal cancer and less comorbidities
  1. Mark Jenkins
  1. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia
  1. Correspondence to: Professor Mark Jenkins, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria VIC 3010, Australia; m.jenkins{at}unimelb.edu.au

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMed.

Context

Eligibility for colorectal cancer screening programmes is usually age-based from 50 to 74 years; the sector of the population in which most disease occurs and, on average, the sector standing to gain most from prevention/early detection. However, given colorectal cancer risk is affected by many factors, a wide spectrum of colorectal cancer risk exists meaning that many within this age range will be at low risk (therefore over screened) and many outside this age range will be at high risk (therefore under screened). What if precision public health approaches were possible where the age cut-offs were substituted by risk or cost-effectiveness thresholds and personalised colorectal cancer risk was calculated taking into account a range of …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.